• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 189-203 of 977 results

11 Preliminary Response: Patent Owner Preliminary Response

Document IPR2020-00324, No. 11 Preliminary Response - Patent Owner Preliminary Response (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

8 Exhibit List: Patent Owner Exhibit List

Document IPR2020-00324, No. 8 Exhibit List - Patent Owner Exhibit List (P.T.A.B. Jan. 13, 2020)

cite Cite Document
Analyze

7 Power of Attorney: Patent Owner Power of Attorney

Document IPR2020-00324, No. 7 Power of Attorney - Patent Owner Power of Attorney (P.T.A.B. Jan. 9, 2020)

cite Cite Document
Analyze

6 Mandatory Notice: Patent Owner Mandatory Notice

Document IPR2020-00324, No. 6 Mandatory Notice - Patent Owner Mandatory Notice (P.T.A.B. Jan. 9, 2020)

cite Cite Document
Analyze

1 Power of Attorney: Petitioners Power of Attorney

Document IPR2020-00324, No. 1 Power of Attorney - Petitioners Power of Attorney (P.T.A.B. Dec. 19, 2019)

cite Cite Document
Analyze

SAXENDA

Docket 206321, Orange Book (Dec. 23, 2014)

cite Cite Docket
Analyze

1008 Exhibit: Ex 1008 Powell et al, Parenteral Peptide Formulations

Document IPR2020-01252, No. 1008-8 Exhibit - Ex 1008 Powell et al, Parenteral Peptide Formulations (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1068 Exhibit: Ex 1068 US PHARMACOPEIA XXII, NATIONAL FORMULARY XVII 19...

Document IPR2020-01252, No. 1068-77 Exhibit - Ex 1068 US PHARMACOPEIA XXII, NATIONAL FORMULARY XVII 1990 Part 1 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1043 Exhibit: Ex 1043 International Publication No EP 0 708 179

Document IPR2020-01252, No. 1043-52 Exhibit - Ex 1043 International Publication No EP 0 708 179 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1067 Exhibit: Ex 1067 MJ Akers, Excipient Drug Interactions in Parenteral Formula...

Document IPR2020-01252, No. 1067-76 Exhibit - Ex 1067 MJ Akers, Excipient Drug Interactions in Parenteral Formulations, (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1033 Exhibit: Ex 1033 International Publication No WO 9943706 Part 1

Document IPR2020-01252, No. 1033-40 Exhibit - Ex 1033 International Publication No WO 9943706 Part 1 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1064 Exhibit: Ex 1064 US Patent No 6,207,684

Document IPR2020-01252, No. 1064-73 Exhibit - Ex 1064 US Patent No 6,207,684 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1013 Exhibit: Ex 1013 REMINGTONS PHARMACEUTICAL SCIENCES 18th ed 199...

Document IPR2020-01252, No. 1013-17 Exhibit - Ex 1013 REMINGTONS PHARMACEUTICAL SCIENCES 18th ed 1990 Part 3 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1035 Exhibit: Ex 1035 International Publication No WO 9808871

Document IPR2020-01252, No. 1035-44 Exhibit - Ex 1035 International Publication No WO 9808871 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1053 Exhibit: Ex 1053 XH Zhou et al, Peptide and Protein Drugs

Document IPR2020-01252, No. 1053-62 Exhibit - Ex 1053 XH Zhou et al, Peptide and Protein Drugs (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 13 14 15 16 17 ... >>